drugset / Trial / NCT03358277
Aripiprazole Added on for DMDD in Youths With ADHD
Completed
58 enrolled
Tri-Service General Hospital (TSGH)
Ministry of Science and Technology, Taiwan · collab
NaSingle-groupOpen-labelTreatment
Summary
Objectives: 1. To investigate the effectiveness of adjuvant with aripiprazole to methylphenidate for disruptive mood dysregulation disorder (DMDD) in youths with attention-deficit/hyperactivity disorder (ADHD) 2. To investigate the neural basis of chronic irritability in youths with functional magnetic resonance imaging (fMRI) 3. To compare the clinical characteristics of youths with comorbid ADHD and DMDD to youths with ADHD only
Timeline
- Start
- 2014-11-19
- Primary completion
- 2017-08-12
- Completion
- 2017-08-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | 2.5 mg | — |
| Subject | Aripiprazole | Other / unclassified | 5 mg | — |
| Subject | Methylphenidate | Small molecule | 10 mg | — |
| Subject | Methylphenidate | Small molecule | 18 mg | — |
| Subject | Methylphenidate | Small molecule | 36 mg | — |
| Subject | Methylphenidate | Small molecule | 40 mg | — |